Hartman Institute for Therapeutic Organ Regeneration

Reprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice.

TitleReprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice.
Publication TypeJournal Article
Year of Publication2017
AuthorsCavelti-Weder C, Zumsteg A, Li W, Zhou Q
JournalCurr Protoc Stem Cell Biol
Volume40
Pagination4A.10.1-4A.10.12
Date Published2017 Feb 02
ISSN1938-8969
KeywordsAcinar Cells, Animals, Basic Helix-Loop-Helix Transcription Factors, Cellular Reprogramming, Homeodomain Proteins, Insulin-Secreting Cells, Maf Transcription Factors, Large, Mice, Nerve Tissue Proteins, Pancreas, Exocrine, Trans-Activators, Transduction, Genetic, Viruses
Abstract

<p>To generate new beta cells after birth is a key focus of regenerative medicine, which could greatly aid the major health burden of diabetes. Beta-cell regeneration has been described using four different approaches: (1) the development of beta cells from putative precursor cells of the adult pancreas, which is termed neogenesis, (2) replication of existing beta cells, (3) differentiation from embryonic or induced pluripotent stem cells, and (4) reprogramming of non-beta cells to beta cells. Studies from the authors' laboratory have shown that beta-cell reprogramming can be achieved by transduction of adult pancreatic tissues with viral constructs containing the three developmentally important transcription factors Pdx1, Ngn3, and MafA. This protocol outlines the generation of a polycistronic construct containing the three transcription factors, the expansion and purification of the polycistronic virus, and in vivo transduction for acinar to beta-cell reprogramming in adult mice. The ultimate goal is to generate beta-like cells that resemble as closely as possible endogenous beta cells in phenotype and function for potential translational applications. © 2017 by John Wiley & Sons, Inc.</p>

DOI10.1002/cpsc.21
Alternate JournalCurr Protoc Stem Cell Biol
PubMed ID28152182
PubMed Central IDPMC5821133
Grant ListR00 DK077445 / DK / NIDDK NIH HHS / United States
R01 DK106253 / DK / NIDDK NIH HHS / United States
U01 DK089536 / DK / NIDDK NIH HHS / United States
UC4 DK116280 / DK / NIDDK NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065